EHBP1L1 and neoplasm: More importantly, by employing an immunocompetent murine RCC model and an immunodeficient nude mice model, we found that EHBP1L1 depletion significantly inhibited tumor growth and prolonged survival, which was mainly due to the enhanced antitumor immune response.